Monoclonal antibody treatment of COVID-19 in a pregnant woman with common variable immunodeficiency
Abstract Background Since the first reported case of COVID-19, infections due to the virus have ranged from mild to severe. Patients with inborn errors of immunity are thought to be at increased risk for infections such as COVID-19 due to the nature of their disease and being immunocompromised. Simi...
Main Authors: | Babak Aberumand, Ramy Kamal, Brock McKinney, Stephen Betschel |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-10-01
|
Series: | Allergy, Asthma & Clinical Immunology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13223-022-00730-x |
Similar Items
-
Common variable immunodeficiency with granulomatous‐lymphocytic interstitial lung disease treated with monoclonal antibodies against COVID‐19: A case report
by: Christian Lechner, et al.
Published: (2023-01-01) -
Common variable immunodeficiency in adults
by: N V Shabashova, et al.
Published: (2016-11-01) -
Management of a patient with common variable immunodeficiency and hepatopathy
by: Lea Grümme, et al.
Published: (2023-06-01) -
Impaired Memory B-Cell Response to Influenza Immunization in Patients With Common Variable Immunodeficiency (CVID)
by: Wei Zhan, et al.
Published: (2021-10-01) -
Pathogenesis of autoimmunity in common variable immunodeficiency (CVID)
by: Klaus eWarnatz, et al.
Published: (2012-07-01)